Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
61,919,993
-
Share change
-
+3,538,172
-
Total reported value
-
$2,094,320,996
-
Put/Call ratio
-
72%
-
Price per share
-
$33.82
-
Number of holders
-
181
-
Value change
-
+$114,605,453
-
Number of buys
-
102
-
Number of sells
-
81
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2019
As of 30 Sep 2019 PTC THERAPEUTICS, INC. - Common Stock (PTCT) had 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,919,993 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, FMR LLC, Point72 Asset Management, L.P., CITADEL ADVISORS LLC, STATE STREET CORP, and GREAT POINT PARTNERS LLC.
This table shows 181 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.